Related Experiment Video
Updated: May 16, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Risk of cardiovascular disease in HIV, hepatitis C, or HIV/hepatitis C patients compared to the general population
L Kakinami1, R C Block, M J Adams
1Department of Community and Preventive Medicine, University of Rochester, Rochester, NY, USA. lisa.kakinami@mcgill.ca
Insights
Hepatitis C (HCV) infection significantly elevates cardiovascular disease (CVD) risk and vascular age in patients. Coinfection with HIV and HCV also increases CVD risk compared to the general population.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Effective antiretroviral therapy allows HIV patients to live longer, increasing concern about their cardiovascular disease (CVD) risk.
- The impact of hepatitis C virus (HCV) coinfection on CVD risk in HIV patients remains unclear.
- Comparing CVD risk in HIV, HCV, or HIV/HCV patients to the general population is crucial for risk stratification.
Purpose of the Study:
- To compare the Framingham Risk Score (FRS) and vascular age differences in persons with HIV, HCV, or HIV/HCV infection against the general population.
- To determine if HCV coinfection modifies CVD risk in HIV-infected individuals.
- To assess CVD risk stratification in co-infected and mono-infected patient groups.
Main Methods:
- Patients with HIV, HCV, and HIV/HCV infection from Rochester, NY clinics (2004-2009) were sampled.
- Uninfected individuals were randomly selected from NHANES and matched on gender, race, and age.
- Multivariable linear regression analyses compared infection groups to matched general population controls.
Main Results:
- HIV/HCV patients showed a 2% higher FRS (p=0.03) and 4.1 years greater vascular age (p=0.01) than the general population.
- HCV patients exhibited a 2.4% higher FRS (p<0.001) and 4.4 years greater vascular age (p<0.001).
- Elevated CVD risk was observed in HIV patients, but not significantly different from the general population.
Conclusions:
- Cardiovascular disease risk is significantly elevated in individuals with HCV infection compared to the general population.
- Coinfection with HIV and HCV also leads to increased cardiovascular disease risk.
- These findings highlight the need for vigilant cardiovascular risk management in HCV-infected and HIV/HCV-coinfected populations.
Background:
As a result of effective antiretroviral therapy HIV patients are living longer, and their risk of cardiovascular disease (CVD) is a growing concern. It remains unknown whether coinfection with hepatitis C (HCV) changes an HIV person's CVD risk, and how the risks compare to the general population. The objective of this study was to compare the Framingham Risk Score (FRS) and vascular age differences in persons with HIV, HCV or HIV/HCV disease to the general population.
Methods:
HIV, HCV, and HIV/HCV patients with clinic visits between 2004 and 2009 were sampled from medical clinics in Rochester, NY. Uninfected persons were randomly selected from the National Health and Nutrition Examination Survey (NHANES), and individually matched on gender, race, and age. We stratified by infection group and conducted separate multivariable linear regression analyses between each infection group and the gender, race, and age matched participants from NHANES.
Results:
Rochester patients (HIV = 239, HCV = 167, HIV/HCV = 182) were compared 3 : 1 with the NHANES participants. After controlling for weight, marital status, current pharmacotherapies and the matching variables of gender, race, and age, HIV/HCV patients had a 2% higher general FRS compared with the general population (p = 0.03), and vascular age differences that were 4.1 years greater (p = .01). HCV patients had a 2.4% higher general FRS than the general population (p < .001), and vascular age differences that were 4.4 years greater (p < .001). CVD risk was elevated but not significantly different between HIV patients and the general population.
Conclusion:
Cardiovascular disease risk is elevated among HIV/HCV and HCV infected persons compared with the general population.
Related Concept Videos
Hepatitis
Sexually Transmitted Infections
Retrovirus Life Cycles
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease IV: Preventive Measures
